Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Banco de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Exp Dermatol ; 25(1): 50-5, 2016 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-26475989

RESUMEN

Bullous pemphigoid (BP) is an autoimmune blistering disease characterized by antibodies (IgG and IgE) targeting cell-substrate adhesion proteins. A variety of BP models suggest that autoantibody-dependent neutrophil degranulation is essential for blister formation. However, lesional biopsies reveal a predominance of eosinophils and few neutrophils. Our goal was to evaluate the role of antibodies and complement in eosinophil localization, degranulation and split formation at the dermo-epidermal junction (DEJ) utilizing a human skin cryosection model of BP paired with a human eosinophilic cell line, 15HL-60. Expression of receptors for IgG (FcγRII), IgE (FcεRI) and complement (CR1 and CR3) was confirmed on 15HL-60 cells using flow cytometry. 15HL-60 expression of granule protein [eosinophil derived neurotoxin (EDN) and eosinophil peroxidase (EPO)] mRNA and their degranulation in vitro was confirmed using RT-PCR and ELISA, respectively. For cryosection experiments, BP or control sera or IgG and IgE antibodies purified from BP sera were utilized in combination with 15HL-60 cells ± fresh complement. Both BP serum and fresh complement were required for localization of 15-HL60 cells to the DEJ. Interestingly, eosinophil localization to the DEJ was dependent on IgG, but not IgE, and complement. However, no subepidermal split was observed. Additionally, the 15HL-60 cells did not degranulate under any experimental conditions and direct application of cell lysate to cryosections did not result in a split. Our observation that eosinophil localization to the DEJ is dependent on IgG mediated complement fixation provides additional insight into the sequence of events during the development of BP lesions.


Asunto(s)
Membrana Basal/metabolismo , Proteínas del Sistema Complemento/inmunología , Eosinófilos/citología , Penfigoide Ampolloso/inmunología , Autoanticuerpos/sangre , Biopsia , Estudios de Casos y Controles , Adhesión Celular , Línea Celular , Ensayo de Inmunoadsorción Enzimática , Peroxidasa del Eosinófilo/metabolismo , Citometría de Flujo , Técnica del Anticuerpo Fluorescente Indirecta , Células HL-60 , Humanos , Inmunoglobulina E/sangre , Inmunoglobulina G/sangre , Microscopía Fluorescente , Neurotoxinas/metabolismo , Neutrófilos/inmunología , Penfigoide Ampolloso/patología , Piel/patología
2.
Brain Behav Immun ; 50: 58-62, 2015 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-25989110

RESUMEN

Increased levels of reactive oxygen species (ROS) such as superoxide anions and hydrogen peroxide have been reported in many cancer cells and they have been implicated in carcinogenesis and tumor progression. Antioxidant enzymes, such as Manganese Superoxide Dismutase (MnSOD or SOD2) and Glutathione Peroxidase-1 (GPx1), act coordinately to neutralize ROS. These enzymes are also thought to contribute to cancer cell resistance to conventional radio-chemo-therapies. Although some relationships have been reported between psychosocial factors and the regulation of antioxidant enzymes, little is known about these relationships in the context of cancer progression. The current study investigated the levels of MnSOD and GPx1in confirmed serous, high-grade tumor tissue from 60 ovarian cancer patients, and explored the relationship between the activity of these enzymes, the levels of tumor norepinephrine (NE), and patient mood as determined via pre-operative questionnaires. MnSOD activity was positively related to depressed mood (p=0.025) and tumor NE (p=0.023). In contrast, GPx1 activity was inversely related to fatigue (p=0.015) and tumor NE (p=0.009), and was positively associated with vigor (p=0.024). These findings suggest that psychological state and adrenergic signaling are linked with antioxidant enzyme activity in ovarian cancer and may have implications for patient treatments and outcomes.


Asunto(s)
Glutatión Peroxidasa/metabolismo , Norepinefrina/metabolismo , Neoplasias Ováricas/enzimología , Neoplasias Ováricas/psicología , Superóxido Dismutasa/metabolismo , Afecto , Anciano , Antioxidantes/metabolismo , Femenino , Humanos , Persona de Mediana Edad , Sistemas Neurosecretores/metabolismo , Glutatión Peroxidasa GPX1
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA